http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7b9d58b4e2fce68835e51eace36206f7
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Cheng |
| name | Linzhao Cheng |
| given-name | Linzhao |
| organization-name | Division of Hematology, Department of Medicine, Baltimore, Maryland, USA; Institute for Cell Engineering, Baltimore, Maryland, USA; Predoctoral Training Program in Human Genetics Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Department of Medicine Johns Hopkins University School of Medicine Baltimore Maryland USA; Division of Life Sciences and Medicine University of Science and Technology of China Hefei Anhui China Stem Cell Program in Institute for Cell Engineering and Division of Hematology, Johns Hopkins University, Baltimore, Maryland. Kimmel Cancer Center, Thomas Jefferson University, Bluemle Life Sciences Building, Room 706, 233 South 10th Street, Philadelphia, PA 19107; Division of Immunology and Hematopoiesis Oncology Center, Room 1-109, Johns Hopkins University School of Medicine, 1650 Orleans Street, Baltimore, MD 21231; Departments of Neurosurgery, Neurology, and Cell Biology, Memorial Sloan Kettering Cancer Center, Rockefeller Research Laboratories, Room 917B, 1275 York Avenue, New York, NY 10021; and Molecular Medicine... Stem Cell Program, Institute for Cell Engineering, School of Medicine, Johns Hopkins University, Baltimore, MD 21205 6 Stem Cell Program, Institute for Cell Engineering, and Department of Gynecology & Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD;; Graduate Immunology Program, Johns Hopkins University, Baltimore, MD;; Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD; Institute for Cell Engineering, and 7 Mammalian Genetics Laboratory, ABL Basic Research Program, NCI-FCRDC, Frederick, MD 21702-1201, USA Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Institute for Cell Engineering, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Division of Immunology and Hematopoiesis, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, Baltimore, MD 21231 From the Departments of Oncology, Pathology, and Pediatrics, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine, Baltimore, MD. Division of Hematology, Department of Medicine Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Stem Cell Program Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Stem Cell Program, Institute for Cell Engineering;; Division of Hematology, Department of Medicine; and Division of Hematology Johns Hopkins University School of Medicine Baltimore Maryland USA Johns Hopkins Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Molecular Medicine and Institute for Cell Engineering, Johns Hopkins University, Baltimore, Maryland, USA Stem Cell Program in Institute for Cell Engineering and Division of Hematology, Johns Hopkins University, Baltimore, MD; Stem Cell Program, Institute for Cell Engineering, Johns Hopkins University, Baltimore, Maryland.; Cellular and Molecular Medicine Training Program, Johns Hopkins University, Baltimore, Maryland.; Division of Hematology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland.; Human Genetics Training Program, Johns Hopkins University, Baltimore, Maryland. Authors' Affiliations: 1Sidney Kimmel Comprehensive Cancer Center, 2Program in Cellular and Molecular Medicine, 3Institute for Cell Engineering and Department of Medicine, 4Bioinformatics, 5Department of Biomedical Engineering, and 6Department of Pediatric Oncology, Johns Hopkins University School of Medicine; 7Department of Pathology and 8Molecular and Comparative Pathobiology, Johns Hopkins Medical Institutions; 9Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland; 10Department of Molecular Biotechnology, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium; and 11OncoMethylome Sciences, SA, Liege, Belgium; Authors' Affiliations: 1Sidney Kimmel Comprehensive Cancer Center, 2Program in Cellular and Molecular Medicine, 3Institute for Cell Engineering and Department of Medicine, 4Bioinformatics, 5Department of Biomedical Engineering, and 6Department of Pediatric Oncology, Johns Hopkins University School of Medicine; 7Department of Pathology and 8Molecular and Comparative Pathobiology, Johns Hopkins Medical Institutions; 9Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore, Maryland; 10Department of Molecular Biotechnology, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium; and 11OncoMethylome Sciences, SA, Liege, Belgium Institute for Cell Engineering and Division of Hematology, Johns Hopkins School of Medicine, Baltimore, MD 21287; and Division of Hematology, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA; Stem Cell Program, Institute for Cell Engineering, Johns Hopkins University, Baltimore, Maryland, USA Division of Hematology, Department of Medicine, Johns Hopkins University, Baltimore, MD From the Departments of Laboratory Medicine and Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei; Graduate Institute of Epidemiology, National Taiwan University, Taipei; and the Department of Medicine, Program of Human Genetics and Molecular Biology, Institute for Cell Engineering, and the Kimmel Cancer Center at Johns Hopkins, The Johns Hopkins University School of Medicine, Baltimore, MD. Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD 21287; Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, MD 21287; Department of Gynecology and Obstetrics, Johns Hopkins Bayview Hospital, Baltimore, MD 21214; and Division of Immunology and Hematopoiesis, Johns Hopkins University School of Medicine Oncology Center, Baltimore, MD 21231 Stem Cell Program, Institute for Cell Engineering, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Division of Hematology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA JOHNS HOPKINS UNIVERSITY From the Basic Research Program, SAIC-Frederick, Laboratory of Experimental Immunology, Laboratory of Molecular Immunoregulation, Center for Cancer Research, National Cancer Institute at Frederick, MD; Division of Immunology and Hematopoiesis, Johns Hopkins University School of Medicine, Baltimore, MD; Clinical Gene Therapy Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD; and Marligen Biosciences, Ijamsville, MD The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Division of Hematology; Johns Hopkins University School of Medicine; Baltimore Maryland From SyStemix, Inc, Palo Alto, CA; the Oncology Gene Therapy Program, The Toronto Hospital, Toronto; and the Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada. Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Department of Stem Cells and Regenerative Medicine, Peking Union Medical College, Tianjin, People's Republic of China Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD; and Division of Hematology and Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD From the Sidney Kimmel Comprehensive Cancer Center; Stem Cell Program, Institute for Cell Engineering; and Department of Medicine, Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD Stem Cell Program Institute for Cell Engineering andJohns Hopkins University School of Medicine, Baltimore, Maryland, USA; Division of Hematology, Department of Medicine Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Stem Cell Program, Institute for Cell Engineering, and Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Stem Cell Resources Center, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Graduate Program in Immunology, Johns Hopkins University, Baltimore, Maryland, USA 4Oncology, and From the Division of Immunology and Hematopoiesis, Johns Hopkins Oncology Center, Johns Hopkins University, Baltimore, MD. Stem Cell Program in Institute for Cell Engineering and Division of Hematology, Johns Hopkins University, Baltimore, MD 21205, USA. lcheng@welch.jhu.edu Division of Hematology, Department of Medicine, and Stem Cell Program, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA; Graduate Program in Immunology, Johns Hopkins University, Baltimore, Maryland, USA; Stem Cell Program, Institute for Cell Engineering and Department of Gynecology and Obstetrics, Johns Hopkins University, Baltimore, Maryland, USA Osiris Therapeutics, Inc., Baltimore, Maryland 21231-3043 Division of Hematology, Department of Medicine, Johns Hopkins University, School of Medicine, Baltimore, United States Division of Hematology, Department of Medicine, Johns Hopkins University, Baltimore, MD; and Division of Hematology, Department of Medicine; John Hopkins University; Baltimore Maryland Stem Cell Program, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Graduate Program in Cellular and Molecular Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Graduate Program in Immunology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Division of Hematology, Department of Medicine and; Stem Cell Program, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD; and Division of Hematology in Department of Medicine , , 21205, Baltimore, MD, USA; Johns Hopkins University School of Medicine , , 21205, Baltimore, MD, USA; Stem Cell Program in the Institute for Cell Engineering , , 21205, Baltimore, MD, USA; Johns Hopkins University School of Medicine , , 21205, Baltimore, MD, USA 1 Cell Biology of Development and Differentiation Group, ABL-Basic Research Program, NCI-FCRDC, PO Box B, Frederick, Maryland 21702-1201, USA From the Departments of Radiology (X.Y., E.A., J.-M.S, D.W., A.K.), Anesthesia and Critical Care Medicine (D.L.), and Oncology (L.C.), Johns Hopkins Hospital, Baltimore, Md. Division of Hematology and Stem Cell Program in the Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD; and Stem Cell Program, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA b Division of Hematology, Department of Medicine, Baltimore, Maryland, USA; c Stem Cell Program in the Institute for Cell Engineering Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Division of Hematology, Department of Medicine, and Stem Cell Program, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD;; Graduate Program in Cellular and Molecular Medicine, Johns Hopkins University School of Medicine, Baltimore, MD Division of Life Sciences and Medicine in the University of Science and Technology of China, China, Johns Hopkins University School of Medicine, USA Division of Hematology, Department of Medicine, and Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287 Department of Hematology The First Affiliated Hospital of USTC Division of Life Sciences and Medicine University of Science and Technology of China Hefei Anhui 230027 China; Blood and Cell Therapy Institute Anhui Provincial Key Laboratory of Blood Research and Applications University of Science and Technology of China Hefei Anhui 230027 China; School of Basic Medical Sciences Division of Life Sciences and Medicine University of Science and Technology of China Hefei Anhui 230027 China The Institute for Cell Engineering, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Department of Gynecology & Obstetrics, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA Division of Hematology Johns Hopkins University School of Medicine Baltimore Maryland USA; Division of Life Sciences and Medicine University of Science and Technology of China Hefei China Institute for Cell Engineering, Johns Hopkins University School of Medicine |
Incoming Links
Total number of triples: 211.